Optometrists and industry leaders alike share exciting new developments in myopia management.
Andrew Sedgwick
Advertisement
Articles by Andrew Sedgwick
Sedgwick said that with the recent FDA authorization of Stellest lenses, he expects SightGlass to eventually find its niche in the US.
Advertisement
Latest Updated Articles
AAOpt 2025: SightGlass Vision CEO Andrew Sedgwick on what's next for DOT spectacle lensesPublished: October 15th 2025 | Updated:
Advertisement
Advertisement
Trending on Optometry Times - Clinical News & Expert Optometrist Insights
1
South Korea's MFDS receives NDA for Tenpoint Therapeutics' Brimochol PF for presbyopia
2
Interventional glaucoma: Redefining the optometrist’s role in modern glaucoma management
3
Fitting the future: How technology is refining specialty lens care
4
.png "Optometry Times"){kind=logo}
